Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

ClinicalTrials.gov ID: NCT00036270

Public ClinicalTrials.gov record NCT00036270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen For 2.5- 3 Years Followed By Exemestane (Aromasin) For A Total Of 5 Years As Adjuvant Therapy For Postmenopausal, Receptor Positive, Node Negative or Node Positive Breast Cancer Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early breast cancer. This Pfizer sponsored trial is part of an international collaboration of investigators conducting 7 similar yet independent studies in 9 countries. This study is designed to be part of the larger TEAM trial where the data from these 7 studies will be combined. A pre-specified analysis of the pooled data will be conducted.

Study identification

NCT ID
NCT00036270
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
9,779 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2001 (Type not available)
Primary completion
Oct 2008 (Actual)
Completion
Feb 2011 (Actual)
Last update posted
Oct 28, 2015

2001 – 2011

United States locations

U.S. sites
179
U.S. states
25
U.S. cities
142
Facility City State ZIP Site status
Pfizer Investigational Site Bessemer Alabama 35022 —
Pfizer Investigational Site Birmingham Alabama 35205 —
Pfizer Investigational Site Birmingham Alabama 35209 —
Pfizer Investigational Site Birmingham Alabama 35211 —
Pfizer Investigational Site Birmingham Alabama 35213 —
Pfizer Investigational Site Birmingham Alabama 35235 —
Pfizer Investigational Site Flagstaff Arizona 86001 —
Pfizer Investigational Site Green Valley Arizona 85614 —
Pfizer Investigational Site Oro Valley Arizona 85737 —
Pfizer Investigational Site Phoenix Arizona 85012 —
Pfizer Investigational Site Safford Arizona 85546 —
Pfizer Investigational Site Scottsdale Arizona 85258 —
Pfizer Investigational Site Sedona Arizona 86336 —
Pfizer Investigational Site Tucson Arizona 85710 —
Pfizer Investigational Site Tucson Arizona 85712 —
Pfizer Investigational Site Tucson Arizona 85745 —
Pfizer Investigational Site Tuscon Arizona 85704 —
Pfizer Investigational Site North Little Rock Arkansas 72117 —
Pfizer Investigational Site Aurora Colorado 80012 —
Pfizer Investigational Site Boulder Colorado 80303 —
Pfizer Investigational Site Colorado Springs Colorado 80909 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Denver Colorado 80220 —
Pfizer Investigational Site Fort Collins Colorado *0524 —
Pfizer Investigational Site Lakewood Colorado 80228 —
Pfizer Investigational Site Lone Tree Colorado 80124 —
Pfizer Investigational Site Longmont Colorado 80501 —
Pfizer Investigational Site Pueblo Colorado 81008 —
Pfizer Investigational Site Thornton Colorado 80260- —
Pfizer Investigational Site Clearwater Florida 33761 —
Pfizer Investigational Site Hudson Florida 34667 —
Pfizer Investigational Site Jacksonville Florida 32204 —
Pfizer Investigational Site Jacksonville Florida 32207 —
Pfizer Investigational Site Lauderhill Florida 33319 —
Pfizer Investigational Site Melbourne Florida 32901 —
Pfizer Investigational Site New Port Richey Florida 34655 —
Pfizer Investigational Site Ocala Florida 34474 —
Pfizer Investigational Site Orange Park Florida 32073 —
Pfizer Investigational Site Palatka Florida 32177 —
Pfizer Investigational Site Plantation Florida 33324 —
Pfizer Investigational Site Saint Augustine Florida 32086 —
Pfizer Investigational Site Alton Illinois 62002 —
Pfizer Investigational Site Arlington Heights Illinois �60005 —
Pfizer Investigational Site Niles Illinois 60714 —
Pfizer Investigational Site Winfield Illinois 60190 —
Pfizer Investigational Site Carmel Indiana 46032 —
Pfizer Investigational Site Fishers Indiana 46037 —
Pfizer Investigational Site Greenfield Indiana 46140 —
Pfizer Investigational Site Indianapolis Indiana 46219 —
Pfizer Investigational Site Indianapolis Indiana 46227 —
Pfizer Investigational Site Shelbyville Indiana 46176 —
Pfizer Investigational Site Terre Haute Indiana 47802 —
Pfizer Investigational Site Cedar Rapids Iowa 52403 —
Pfizer Investigational Site Kansas City Kansas 66112 —
Pfizer Investigational Site Shawnee Mission Kansas 66204 —
Pfizer Investigational Site Westminster Maryland 21157 —
Pfizer Investigational Site North Adams Massachusetts 01247 —
Pfizer Investigational Site Pittsfield Massachusetts 01201 —
Pfizer Investigational Site Burnsville Minnesota 55337 —
Pfizer Investigational Site Edina Minnesota 55435-2150 —
Pfizer Investigational Site Maplewood Minnesota 55109 —
Pfizer Investigational Site Saint Paul Minnesota 55102-2389 —
Pfizer Investigational Site Woodbury Minnesota 55125 —
Pfizer Investigational Site Columbia Missouri 65201 —
Pfizer Investigational Site Kansas City Missouri 64111 —
Pfizer Investigational Site Kansas City Missouri 64131 —
Pfizer Investigational Site Kansas City Missouri 64154 —
Pfizer Investigational Site Lee's Summit Missouri 29307 —
Pfizer Investigational Site Lee's Summit Missouri 64064 —
Pfizer Investigational Site St Louis Missouri 63136 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Santa Fe New Mexico 87505 —
Pfizer Investigational Site Albany New York 12206 —
Pfizer Investigational Site Albany New York 12208 —
Pfizer Investigational Site Amsterdam New York 12010 —
Pfizer Investigational Site Brockport New York 14420 —
Pfizer Investigational Site Canandaigua New York 14424 —
Pfizer Investigational Site Geneva New York 14456 —
Pfizer Investigational Site Hudson New York 12534 —
Pfizer Investigational Site Latham New York 12110-0610 —
Pfizer Investigational Site Rexford New York 12148 —
Pfizer Investigational Site Troy New York 12180 —
Pfizer Investigational Site Asheville North Carolina 28801 —
Pfizer Investigational Site Cary North Carolina 27518 —
Pfizer Investigational Site Durham North Carolina 27704 —
Pfizer Investigational Site Elizabeth City North Carolina 27909 —
Pfizer Investigational Site Hickory North Carolina 28602 —
Pfizer Investigational Site Kernersville North Carolina 27284 —
Pfizer Investigational Site Lexington North Carolina 27295 —
Pfizer Investigational Site Raleigh North Carolina 27607 —
Pfizer Investigational Site Raleigh North Carolina 27614 —
Pfizer Investigational Site Seneca North Carolina 29672 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Kettering Ohio 45409 —
Pfizer Investigational Site Bartlesville Oklahoma 74006 —
Pfizer Investigational Site Norman Oklahoma 73071 —
Pfizer Investigational Site Oklahoma City Oklahoma 73102 —
Pfizer Investigational Site Oklahoma City Oklahoma 73104-5020 —
Pfizer Investigational Site Oklahoma City Oklahoma 73109 —
Pfizer Investigational Site Oklahoma City Oklahoma 73112-4416 —
Pfizer Investigational Site Tulsa Oklahoma 74104 —
Pfizer Investigational Site Tulsa Oklahoma 74133 —
Pfizer Investigational Site Tulsa Oklahoma 74136 —
Pfizer Investigational Site Eugene Oregon 97401 —
Pfizer Investigational Site Portland Oregon 97210 —
Pfizer Investigational Site Portland Oregon 97213-2996 —
Pfizer Investigational Site Portland Oregon 97216 —
Pfizer Investigational Site Portland Oregon 97225 —
Pfizer Investigational Site Springfield Oregon 97477 —
Pfizer Investigational Site Tualatin Oregon 97062 —
Pfizer Investigational Site Kingston Pennsylvania 18704-5535 —
Pfizer Investigational Site Easley South Carolina 29640 —
Pfizer Investigational Site Greenville South Carolina 29605 —
Pfizer Investigational Site Greenville South Carolina 29615 —
Pfizer Investigational Site Spartanburg South Carolina 29307 —
Pfizer Investigational Site Abilene Texas 79606-5208 —
Pfizer Investigational Site Arlington Texas 76012 —
Pfizer Investigational Site Arlington Texas 76014 —
Pfizer Investigational Site Austin Texas 78731 —
Pfizer Investigational Site Austin Texas 78745 —
Pfizer Investigational Site Beaumont Texas 77702-1449 —
Pfizer Investigational Site Bedford Texas 76022' —
Pfizer Investigational Site Dallas Texas 75230-2510 —
Pfizer Investigational Site Dallas Texas 75231-4400 —
Pfizer Investigational Site Dallas Texas 75237 —
Pfizer Investigational Site Dallas Texas 75246 —
Pfizer Investigational Site Denton Texas 76210 —
Pfizer Investigational Site El Paso Texas 79902 —
Pfizer Investigational Site El Paso Texas 79915 —
Pfizer Investigational Site Fort Worth Texas 76104 —
Pfizer Investigational Site Fredericksburg Texas 78624 —
Pfizer Investigational Site Garland Texas 75042 —
Pfizer Investigational Site Houston Texas 77024 —
Pfizer Investigational Site Irving Texas 75061-224 —
Pfizer Investigational Site Kerrville Texas 78028 —
Pfizer Investigational Site Lewisville Texas 75067 —
Pfizer Investigational Site Longview Texas 75601 —
Pfizer Investigational Site McAllen Texas 78503 —
Pfizer Investigational Site Mesquite Texas 75150 —
Pfizer Investigational Site Midland Texas 79701 —
Pfizer Investigational Site New Braunfels Texas 78130 —
Pfizer Investigational Site Odessa Texas 79761 —
Pfizer Investigational Site Paris Texas 75460-5004 —
Pfizer Investigational Site Plano Texas 75075-7787 —
Pfizer Investigational Site Round Rock Texas 78681 —
Pfizer Investigational Site San Antonio Texas 78212 —
Pfizer Investigational Site San Antonio Texas 78217 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site San Antonio Texas 78258-3912 —
Pfizer Investigational Site Sherman Texas TX 75090-0504 —
Pfizer Investigational Site Tyler Texas 75702 —
Pfizer Investigational Site Waco Texas 76712 —
Pfizer Investigational Site Webster Texas 77598 —
Pfizer Investigational Site Weslaco Texas 78596 —
Pfizer Investigational Site Wichita Falls Texas 76310 —
Pfizer Investigational Site Chesapeake Virginia 23320 —
Pfizer Investigational Site Christianburg, Virginia 24073 —
Pfizer Investigational Site Christianburg Virginia 24073 —
Pfizer Investigational Site Fairfax Virginia 22031 —
Pfizer Investigational Site Gainesville Virginia 20155 —
Pfizer Investigational Site Hampton Virginia 23666 —
Pfizer Investigational Site Newport News Virginia 23606 —
Pfizer Investigational Site Norfolk Virginia 23502 —
Pfizer Investigational Site Pulaski Virginia 24301 —
Pfizer Investigational Site Roanoke Virginia 24101 —
Pfizer Investigational Site Salem Virginia 24153 —
Pfizer Investigational Site Williamsburg Virginia 23188 —
Pfizer Investigational Site Woodbridge Virginia 22191 —
Pfizer Investigational Site Wytheville Virginia 24382 —
Pfizer Investigational Site Burien Washington 98166 —
Pfizer Investigational Site Edmonds Washington 98026 —
Pfizer Investigational Site Seattle Washington 98133-8414 —
Pfizer Investigational Site Seattle Washington 98133 —
Pfizer Investigational Site Spokane Washington 99202 —
Pfizer Investigational Site Spokane Washington 99216 —
Pfizer Investigational Site Spokane Washington 99218 —
Pfizer Investigational Site Vancouver Washington 98684-6930 —
Pfizer Investigational Site Vancouver Washington 98684 —
Pfizer Investigational Site Vancouver Washington 98686 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00036270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00036270 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →